This week, San Diego-based company Biolinq raked in $58 million in a funding round led by Alpha Wave Ventures, bringing its total funding to date to $178 million. The company, founded in 2012, is ...
The FDA has granted 510(k) clearance to allow over-the-counter sale of a needle-free continuous glucose monitor, according to ...
The US Food and Drug Administration (FDA) has granted de novo classification to Biolinq Shine, a wearable biosensor that would be the first needle-free continuous glucose monitoring (CGM) device to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results